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Background: Conclusive evidence indicating an effective treatment for carpal tunnel syndrome (CTS), a common
entrapment neuropathy, is lacking. Ultrasound therapy (US therapy) has long been used as one of the combination
treatments for CTS. In addition, paraffin bath therapy has been applied widely as a physical modality in treating
patients with hand conditions. The purpose of this randomized trial was to compare the efficacy of combining a wrist
orthosis with either US therapy or paraffin bath therapy in treating CTS patients.
Methods: Patients with CTS were randomized into two groups. All patients received a wrist orthosis. Twice per week,
one group underwent paraffin therapy, and the other group underwent ultrasound therapy. Each patient received a
questionnaire, physical examination and nerve conduction study of the upper extremities before and after treatment
for eight weeks.
Results: Sixty patients were recruited, and 47 completed the study. Statistical analysis revealed significant improvements
in symptom severity scores in both groups. After adjusting for age, gender and baseline data, the analysis of covariance
revealed a significant difference in the functional status score between two groups.
Conclusions: The combination of ultrasound therapy with a wrist orthosis may be more effective than paraffin therapy
with a wrist orthosis.
Trial registration: Clinicaltrial.gov: NCT02278289 Oct 28, 2014
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Carpal tunnel syndrome (CTS) is a common entrapment
neuropathy that causes symptoms of pain, numbness and
paresthesia in the distribution of the median nerve and
may even cause atrophy of the thenar muscle [1,2]. For
patients with mild to moderate symptoms, nonsurgical
treatments, such as local steroid injection, oral medica-
tion, wrist orthoses, therapeutic exercise, ultrasound ther-
apy (US therapy), low-level laser and paraffin bath have
been implemented clinically [1,3,4]. However, conclusive
evidence on the best treatment for patients with CTS is
lacking.* Correspondence: d97841001@gmail.com
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unless otherwise stated.For years, US therapy has been used as one of the com-
bination treatments for CTS [1-3,5]. The mechanism of
US therapy includes thermal and nonthermal effects. The
thermal effect occurs when acoustic waves penetrate the
tissue and produce molecular vibration, which results in
heat production and facilitates pain relief. [6] The non-
thermal effect of US therapy includes cavitation, media
motion and standing waves, which might elicit anti-
inflammatory and tissue-stimulating effects [7,8]. Several
clinical trials have revealed US therapy has a positive effect
on patients with CTS [5,9]. However, Cochrane’s 2013 re-
view concluded that there is still insufficient evidence to
support that US therapy is more effective than placebo or
other nonsurgical interventions for CTS [10]. Additional
research is still needed to compare the effectiveness of US
therapy with other modalities for patients with CTS, par-
ticularly in the long term.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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modality in treating patients with hand conditions, such
as rheumatoid arthritis, osteoarthritis and CTS [4,11,12].
Paraffin therapy provides superficial heat to the hands,
which can both relieve pain and improve local circula-
tion [6,13]. Previous studies have revealed that paraffin
therapy could improve pain and finger joint range of
motion in patients with hand arthritis [11,12]. Symptom
improvements were also observed in patients with CTS
after receiving combination treatments with paraffin
therapy and a wrist orthosis [4]. However, to the best of
our knowledge, no previous clinical trial has compared
the effectiveness of paraffin bath with US therapy for
CTS patients.Purpose
The purpose of this exploratory study is to compare the
combination of a wrist orthosis with either US therapy
or paraffin bath therapy in the treatment of CTS pa-
tients. We hypothesized that US therapy might be more
effective than paraffin therapy because it provides both
thermal and nonthermal effects.Methods
Patients and controls
The Institutional Review Board of our hospital (Taipei
Tzuchi Hospital Institutional Review Board Committee)
approved this study, and patients provided informed
consent prior to the study. Sixty individuals diagnosed
with CTS were recruited from the Department of Phys-
ical Medicine and Rehabilitation in one community hos-
pital during 2010 and 2011. Study inclusion criteria
required patients to have subjective symptoms (such as
pain and/or numbness in the median nerve distribution
of the digits or nocturnal pain). Furthermore, patients
were required to have either a positive Phalen’s sign or a
positive Tinel’s sign along with electrophysiological evi-
dence of CTS. We excluded patients with (1) age younger
than 18 years old; (2) underlying medical disorders, such
as diabetes mellitus, renal failure, autoimmune disease or
hypothyroidism; and (3) pregnancy, previous wrist trauma
or surgery.
All eligible patients were invited, and the participants
were randomly assigned to two groups. A total of 60 lots
were prepared with 30 lots for each group, and each lot
was sealed in a non-transparent envelope with the same
appearance. All envelopes were randomly mixed together
numerous times. Finally, the envelopes were marked from
1 to 60 by an assistant who was not involved in the mixing
process, and the study nurse simply picked up the lot se-
quentially. The allocations were concealed with the use of
packages of prescription orders, which were given by the
nurse to the physical therapists, and the therapy programswere administered by physical therapists who did not par-
ticipate in evaluating the study outcome.
The participants were randomly allocated into two
groups. One group received paraffin therapy and a wrist
orthosis, and the other group received US therapy and a
wrist orthosis. Custom-made neutral wrist orthoses were
given to all the patients, who were instructed to wear
the wrist orthoses while sleeping for at least eight weeks.
A CONSORT flowchart describing the process of par-
ticipant randomization and intervention is depicted in
Figure 1.
A series of physical examinations and nerve conduc-
tion studies (NCSs) were performed on each patient.
Physical examination included the palmar pinch power
test, the Semmes-Weinstein Monofilament sensory test,
Tinel’s test and Phalen’s test. Participants completed a
set of questionnaires, including the Boston CTS ques-
tionnaire and several questions involving basic demo-
graphic information. Numbness and pain were assessed
using a 10-cm visual analog scale (VAS).
After receiving the designated 8-week therapy, all pa-
tients were re-evaluated using the same clinical examina-
tions, questionnaires and NCSs. The outcomes of the
physical examination and the NCSs were assessed by
physiatrists who were not aware of the group assignments.Paraffin therapy
Patients in the paraffin therapy group were treated with
the dip-and-wrap method of paraffin bath therapy in the
hospital twice per week for 8 weeks. The temperature of
the paraffin bath was maintained at approximately 55°C
(Parabath, Hygenic Corporation, Akron, OH, USA). The
whole procedure is described as follows. Patients dipped
their affected hands into the paraffin wax. Next, they
waited for the paraffin wax to harden and then dipped
their hands again into the paraffin wax. This step was re-
peated 5 times. When the last paraffin layer hardened, it
was covered with plastic wrap and a towel. After 20 mi-
nutes of heating, the paraffin was removed [12].Ultrasound therapy
Patients in the ultrasound group were treated with US
therapy for 5 minutes each session, twice per week for
8 weeks. The US machine was set at a frequency of
1 MHz, an intensity of 1.0 W/cm2, in pulsed mode (1:4)
with a transducer 5 cm2 in size (Therasound 3.5, Rich-
Mar Corporation, Inola, OK, USA), and with aquasonic
gel as couplant [3]. The transducer was placed over the
wrist carpal tunnel area, ranging from wrist crease to
palmar region. A stroking method was used with a
sonation area of approximately 5 × 5 cm2. The machine
was calibrated, and the output was adjusted regularly
with a simple underwater balance.
Figure 1 Flowchart of patients’ recruitment.
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The patients were evaluated with the Boston CTS ques-
tionnaire, a pain scale, physical examinations and NCSs
before and after treatment for eight weeks.
Primary outcome
The primary outcome was the functional status scale of
the Boston CTS questionnaire. The Boston CTS question-
naire is a self-administered outcome measurement for
CTS patients, consisting of two parts: a symptom severity
scale (11 questions) and a functional status scale (8 ques-
tions). All of the answers were scored from 1 to 5 accord-
ing to the patient’s clinical condition, such that 1 indicated
no symptoms, and 5 indicated the most severe symptoms.
The questionnaire’s reproducibility, internal consistency
and responsiveness were validated in the previous paper
[14]. The functional status scale of the Boston CTS ques-
tionnaire was chosen as the primary outcome because it is
closely correlated with the patient’s ability to perform daily
activities. The goal of rehabilitation is to improve the func-
tional status of patients, rather than only symptom relief.
Secondary outcomes
The secondary outcomes were the symptom severity
scale of the Boston CTS questionnaire, the pain scale,
changes in the monofilament sensory test, palmar pinchpower and the distal sensory and motor latencies of the
median nerve.
Physical examinations
Phalen’s test was performed by asking the patients to
fully flex their wrist for 60 seconds. A positive test oc-
curred when patients experienced symptoms of numb-
ness and tingling in the median nerve distribution [15].
Tinel’s sign was elicited by gently tapping the median
nerve at wrist level. This test was considered positive
when patients reported signs of a tingling sensation or
shooting pain along the median nerve distribution of the
hand [16]. Palmar pinch strength was measured by
pressing the thumb and the index finger tip against a
standard dynamometer. This procedure was repeated 3
times, and a mean score was obtained [17].
The Semmes-Weinstein monofilament sensory test
was measured by applying force-calibrated nylon fila-
ment to the fingertips with the wrist in a neutral supine
position. Each type of filament was pressed perpendicu-
larly against the fingertips until the filament bent into a
C shape. This examination was considered positive if the
patient was able to correctly identify which digit the
monofilament was touching with his/her eyes closed. A
weighted score from 1 to 5 was acquired according to
each filament’s calculated force [14]. We recorded the
Table 1 Frequency distributions (percentages) of




Paraffin therapy US therapy
n = 23, n (%) n = 24, n (%)
Personal characteristics
Age, mean±SD, yrs 51.9±8.8 48.8±11.2
Body mass index, mean±SD 25.7±4.5 25.0±3.7
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the scores to analyze as a continuous variable.
Nerve conduction study
Median and ulnar nerve sensorimotor NCSs were con-
ducted on all patients utilizing Neuropack M1 MEB-
9200 J/K electrodiagnostic equipment (Nihon Kohden
Corporation, Tokyo, Japan) in a quiet, air-conditioned
room (26°C). The patients were prepared in the supine
position with their skin temperature measured on the
palms and maintained above 32°C. Standard techniques
of supramaximal percutaneous stimulation with a con-
stant current stimulator and surface recording were used
for the NCS. Median motor nerve conduction and distal
motor latency were measured by placing a stimulating
electrode at the wrist and a recording electrode on the
abductor pollicis brevis muscle 8 cm from the stimulus
electrode. A standard distance (14 cm) was maintained
between the stimulator and recording electrodes for the
sensory nerve conduction studies [18]. The ring finger
difference was calculated as the median nerve peak latency
minus the ulnar nerve peak latency [19]. The diagnosis
of CTS was established if at least one of three criteria
was achieved: (1) distal motor latency >4.4 millisec-
onds, (2) distal sensory latency >3.4 milliseconds [20]
or (3) median-ulnar distal sensory latency difference
(ring difference) >0.4 milliseconds [19].
Sample size
For sample size estimation, previous randomized, con-
trolled trial studies, conducted in CTS patients receiving
carpal tunnel injection, suggested that 26 subjects per
group would provide 90% statistical power and a 5% sig-
nificance level by two-sided tests to detect a significant
decrease in the Boston CTS questionnaire score from
1.6 to 2.0 [21,22]. To compensate for a 15 to 20% drop-
out rates, we recruited 30 subjects per group.Male 3 (13.0) 2 (8.3)
Married 17 (77.3) 17 (70.8)
Employed 10 (40.5) 14 (58.3)
Smoking habit 0 (0.0) 1 (4.2)
Right-hand dominant 21 (95.5) 23 (100.0)
Bilateral hands involved 20 (87.0) 17 (70.8)
Educational level
College/University 7 (30.4) 9 (37.5)
Senior High 8 (34.8) 11 (45.8)
Junior High or below 8 (34.8) 4 (16.7)
Household monthly income (US$)
<1200 8 (34.8) 3 (12.5)
1200-3500 10 (43.5) 16 (66.7)
>3500 5 (21.7) 5 (20.8)Statistical analysis
The following data were analyzed: (1) descriptive statis-
tics to summarize the participants' basic demographics;
(2) the baseline and follow-up scores for patient-
reported outcomes (PROs; including the symptom severity
scale, the functional status scale and pain intensity), using
paired t-tests for each patient; (3) the differences in
changes in the PROs after treatment between the groups
by analysis of covariance (ANCOVA), with adjustments
for age, sex and the baseline data for each item before
treatment to accommodate individual differences; (4) the
baseline and follow-up physical examinations and NCS
data for each affected hand, using the generalized estimate
equation (GEE) method, which is a quasi-likelihood ap-
proach for correlated data that does not fully specify thedistribution of responses in each cluster, while considering
that these examinations were performed on both hands
for those patients who had bilateral CTS; this GEE
method was applied with the subjects as clusters, and in
this model, the two hands of each individual were treated
as correlated [23]; and (5) the differences in changes in
the physical examination and NCS data between the two
studied groups using the GEE model, with age, sex and
baseline values as covariates. In addition, we calculated
the effect size (ES; mean changes in scores divided by
baseline standard deviation) for PROs. All of the statistical
analyses were performed using the SAS statistical software
package, version 9.2. (SAS Institute Inc., Cary, NC, USA).Results
Patient characteristics and patient-reported outcomes
Seventy-eight patients were enrolled in this study, and 18
patients were excluded after being assessed for eligibility.
Among the excluded patients, nine did not meet the in-
clusion criteria and nine declined to participate. A total of
60 patients with CTS were recruited and randomized into
the two study groups. Forty-seven patients completed the
study. Seven and six patients were unable to complete the
study in the paraffin and US therapy groups, respect-
ively (Figure 1). Table 1 summarizes the demographic
Table 3 Comparison of the results of physical examinations
and NCSs in CTS patients
Treatment group P valueb
Paraffin therapy US therapy




Difference (AT-BT) 1.2±3.5 1.2±3.3
P valuea 0.03 0.05
Palmar pinch power (kg) 0.34
BT 3.2±1.8 3.2±1.2
AT 3.6±1.5 3.6±1.1
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shown in Table 1, the mean ages of the patients in the
paraffin and US therapy groups were 51.9 ± 8.8 and
48.8 ± 11.2 years, respectively. More than half of the pa-
tients were female and had bilateral CTS.
After treatment, significant improvements in symptom
severity scores were seen in both groups (Table 2). The
effect size (ES) of the symptom severity scores was 0.63
for both groups. However, significant improvements in
functional status scores (ES 0.38) and pain scales (ES
0.74) were only seen in the US therapy group. An effect
size of 0.3 to 0.8 is considered a "moderate" effect [24].
After adjusting for age, gender and baseline data, the
ANCOVA analysis revealed significant differences in the
functional status scores between the two study groups.Difference (AT-BT) 0.4±1.8 0.5±1.4
P valuea 0.44 0.01
Distal motor latency of




Difference (AT-BT) -0.3±0.6 -0.03±0.6
P valuea 0.77 0.91Physical findings and NCSs
A significant improvement in the monofilament sensory
test was observed in the paraffin group, and a significant
improvement in the palmar pinch power test was ob-
served in the US therapy group as well (Table 3). How-
ever, NCSs did not detect significant changes in theTable 2 Comparison of the CTS Questionnaire and the
pain scale in CTS patients
Treatment group P valueb
Paraffin therapy US therapy
(n = 23) (n = 24)
Functional status score 0.04
BT 1.7±0.6 1.8±0.8
AT 1.8±0.9 1.6±0.7
Difference (AT-BT) 0.1±0.9 -0.3±0.4
Effect size 0.17 0.38
P valuea 0.88 0.0017
Symptom severity score 0.51
BT 2.5±0.8 2.6±0.8
AT 1.9±0.7 2.1±0.8
Difference (AT-BT) -0.5±0.7 -0.5±0.7
Effect size 0.63 0.63




Difference (AT-BT) -5.7±24.1 -14.2±27.3
Effect size 0.27 0.74
P valuea 0.29 0.01
Abbreviations: CTS carpal tunnel syndrome; US ultrasound; BT before treatment;
AT after treatment.
aPaired t test.
bANCOVA comparison of differences in changes after treatment between groups
after adjusting for age, gender and baseline values.
Distal sensory latency of
the median nerve (ms)
BT 3.7±0.9 3.6±0.8 0.83
AT 3.4±0.8 3.6±1.4
Difference (AT-BT) -0.2±0.9 0.03±1.1
P valuea 0.11 0.91
Abbreviations: CTS carpal tunnel syndrome; NCS nerve conduction study; US
ultrasound; BT before treatment; AT after treatment.
aPaired t test (generalized estimating equation).
bComparison of differences in changes after treatment between groups after
adjusting for age, gender and baseline values (generalized estimating equation).distal motor or sensory latencies of the median nerve in
either group. Despite adjusting for baseline data, age and
sex, there were no significant differences between the
two study groups in any of the outcomes of the physical
examinations or NCSs (Table 3).Discussion
In this study, we found that US therapy tends to be
more effective than paraffin therapy in treating CTS pa-
tients. Patients who underwent US therapy and a wrist
orthosis not only experienced improvements in their
functional status scores compared to those receiving
paraffin therapy and a wrist orthosis but also showed
statistically significant improvements in their symptom
severity scores and palmar pinch power. In contrast, pa-
tients who underwent paraffin therapy and a wrist orth-
osis only experienced significant improvements in their
symptom severity scores.
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used in US therapy for CTS patients [1,3,5,9,25,26]. Gen-
erally, in US therapy, continuous mode is chosen when
the thermal effect is desired, while pulsed mode is ap-
plied when the nonthermal effect is preferred [13]. Al-
though the study conducted by Dincer et al. revealed
symptom improvements after continuous mode US ther-
apy in CTS patients [9], Oztas et al. reported a pro-
longed distal motor latency and a decrease in motor
nerve conduction velocity after treatment with continu-
ous mode US therapy [26]. These findings implied that
though continuous mode US therapy was able to im-
prove the symptoms in CTS patients, selective heating
of the median nerve might lead to temporal conduction
block [26]. On the contrary, pulsed mode US therapy ef-
fectively enhanced peripheral nerve regeneration in an
animal study, possibly through the mechanisms of local
blood vessel dilatation, nerve sprouting stimulation,
Schwann cell activation and chemotactic stimulator re-
lease [27].
This study utilized pulsed mode US therapy on CTS pa-
tients and observed improvements in subjective symptoms
and palmar pinch power, similar to previous studies [1,3].
However, we did not note significant improvements in dis-
tal motor and sensory latencies of the median nerve after
eight weeks of treatment. These findings corroborate stud-
ies conducted by Yildiz et al. and Baysal et al., who were
also unable to find significant improvement in distal laten-
cies of the median nerve in CTS patients after applying
pulsed mode US therapy and followed up for eight weeks
[3,25]. This negative result might be because A fibers in
the peripheral nerve system are measured mostly in clin-
ical NCSs, but C fibers, which transmit somatic pain sig-
nals, are more sensitive to US effects than A fibers
[6,28,29]. This difference might explain the fact that, des-
pite significant symptom improvements in our study,
NCSs did not detect significant improvements in distal
motor and sensory latencies of the median nerve. More-
over, delayed recovery of nervous tissue could contribute
to the lack of improvement seen in NCSs. As shown in
Harris et al.’s study, CTS patients who underwent surgical
decompression experienced delayed electrophysiological
recovery of up to six months [30]. Inadequate follow-up
time may underestimate the electrophysiological improve-
ment; thus, further study with a longer follow-up time is
recommended.
Paraffin therapy is a superficial heat physical agent that
uses conduction to transfer heat. Its therapeutic effects
include increasing blood flow, producing analgesic ef-
fects, decreasing chronic inflammation, improving con-
nective tissue elasticity and stimulating general muscle
relaxation [6,31]. In this study, patients receiving a com-
bination treatment of paraffin therapy and a wrist orth-
osis exhibited improvements in symptom severity scoresand in the monofilament sensory test, consistent with a
previous study [4]. These findings could be regarded as a
validation of the baseline measurements of this trial. In
the US therapy group, a significant improvement in
pinch power was noted, in addition to symptom im-
provements, which further improved patients' functional
status. This result might be partially contributed by the
nonthermal effect of pulsed US therapy.
Though it requires more manpower to implement US
therapy than paraffin therapy, combination treatment
with US therapy and a wrist orthosis is recommended
because of its superior effect on functional status and
possibly on nerve regeneration. Further study to com-
pare the effectiveness of pulsed vs. continuous US ther-
apy in CTS patients is suggested.
This study has several limitations. First, because this
study was performed in the Department of Physical
Medicine and Rehabilitation, the patients usually suf-
fered from mild to moderate symptoms. Therefore, we
should remain cautious in our attempts to generalize
our findings to patients with more severe symptoms.
Second, this study used a combination treatment of a
wrist orthosis with either US or paraffin therapy because
it would have been unethical to withhold wrist orthoses
when they have been reported to be effective [9]. There-
fore, the treatment effects might partially originate from
the wrist orthoses. Third, because approximately 20% of
the participants did not complete this study, we could
not perform the intention-to-treat analyses. To examine
the potential bias caused by loss of follow-up, we com-
pared the demographic and baseline symptoms severity
scales, functional status scores and pain scales between
the patients who completed the study and those who did
not. The results revealed no significant differences be-
tween the follow-up and non-follow-up groups. Thus,
we believe the potential bias may be minimal because all
patients were instructed in the same manner and were
randomized into two different groups. Fourth, because
this study compared the two studied groups regarding
their functions, symptoms, pain and results on four clin-
ical tests, we were concerned about multiplicity issues.
Of the 7 outcomes evaluated, only the primary outcome
(functional status score) exhibited a significant difference
between the two studied groups. Thus, further random-
ized, controlled trials with long-term follow-ups could
be needed to validate these results.
Conclusions
To improve the functional status of CTS patients, a
combination of ultrasound therapy and a wrist orthosis
may be more effective than a combination of paraffin
therapy and a wrist orthosis. Since this is an exploratory
trial, further confirmatory testing is suggested to justify
the efficacy of these two treatments.
Chang et al. BMC Musculoskeletal Disorders 2014, 15:399 Page 7 of 7
http://www.biomedcentral.com/1471-2474/15/399Abbreviations
CTS: Carpal tunnel syndrome; US therapy: Ultrasound therapy; NCSs: Nerve
conduction studies; VAS: Visual analog scale; PRO: Patient-reported outcomes;
ANCOVA: Analysis of covariance; GEE: Generalized estimate equation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YWC participated in study design/data analysis and drafted the manuscript,
and acted as first author. SFH carried out nerve conduction studies. Yu-SH
helped in performing clinical examinations of the subjects. HLC helped in
implementing therapy programs. KCL participated in data collection and
interpretation. Yi-SH assisted to obtain the funding, supervised the study design
and data analysis, revised the manuscript and acted as the corresponding
author. All authors read and approved the final manuscript.
Acknowledgments
This study is mainly supported by a grant of Taipei Tzuchi Hospital,
Buddhist Tzuchi Medical Foundation (TCRD-TPE-99-25) and partially supported
by a grant from the National Science Council, Executive Yuan, Taiwan
(NSC102-2314-B-303-001). We also appreciate for the statistical analysis support
to Tsung-Cheng Hsieh, PhD, Institute of Medical Sciences, Buddhist Tzu-Chi
University.
This article has been presented at the 2nd Asian Congress on Pain, Asian
Australasian Federation of Pain Societies, March 27–30, 2014, Taipei, Taiwan.
Author details
1Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital,
Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan. 2Department
of Medicine, Tzu Chi University, Hualien, Taiwan. 3Department of Physical
Medicine and Rehabilitation, Keelung Hospital Ministry of Health and Welfare,
Keelung City, Taiwan.
Received: 5 April 2014 Accepted: 10 November 2014
Published: 26 November 2014
References
1. Bakhtiary AH, Rashidy-Pour A: Ultrasound and laser therapy in the treatment
of carpal tunnel syndrome. Aust J Physiother 2004, 50:147–151.
2. Gerritsen AAM, de Krom MCTFM, Struijs MA, Scholten RJPM, de Vet HCW,
Bouter LM: Conservative treatment options for carpal tunnel syndrome:
a systematic review of randomised controlled trials. J Neurol 2002,
249:272–280.
3. Baysal O, Altay Z, Ozcan C, Ertem K, Yologlu S, Kayhan A: Comparison of
three conservative treatment protocols in carpal tunnel syndrome. Int J Clin
Pract 2006, 60:820–828.
4. Horng YS, Hsieh SF, Tu YK, Lin MC, Horng YS, Wang JD: The comparative
effectiveness of tendon and nerve gliding exercises in patients with
carpal tunnel syndrome: a randomized trial. Am J Phys Med Rehabil 2011,
90:435–442.
5. Ebenbichler GR, Resch KL, Nicolakis P, Wiesinger GF, Uhl F, Ghanem AH,
Fialka V: Ultrasound treatment for treating the carpal tunnel syndrome:
randomised "sham" controlled trial. BMJ 1998, 316:731–735.
6. Braddom RL: Physical Medicine and Rehabilitation. Philadelphia: PA:Elsevier
Health Sciences; 2010.
7. Byl NN, McKenzie AL, West JM, Whitney JD, Hunt TK, Scheuenstuhl HA:
Low-dose ultrasound effects on wound healing: a controlled study with
Yucatan pigs. Arch Phys Med Rehabil 1992, 73:656–664.
8. ElHag M, Coghlan K, Christmas P, Harvey W, Harris M: The anti-inflammatory
effects of dexamethasone and therapeutic ultrasound in oral surgery.
Br J Oral Maxillofac Surg 1985, 23:17–23.
9. Dincer U, Cakar E, Kiralp MZ, Kilac H, Dursun H: The effectiveness of conservative
treatments of carpal tunnel syndrome: splinting, ultrasound, and low-level
laser therapies. Photomed Laser Surg 2009, 27:119–125.
10. Page MJ, O'Connor D, Pitt V, Massy-Westropp N: Therapeutic ultrasound
for carpal tunnel syndrome. Cochrane Database Syst Rev 2013, 3:CD009601.
11. Ayling J, Marks R: Efficacy of paraffin Wax baths for rheumatoid arthritic
hands. Physiotherapy 2000, 86:190–201.12. Dilek B, Gozum M, Sahin E, Baydar M, Ergor G, El O, Bircan C, Gulbahar S:
Efficacy of paraffin bath therapy in hand osteoarthritis: a single-blinded
randomized controlled trial. Arch Phys Med Rehabil 2013, 94:642–649.
13. Prentice W: Therapeutic Modalities in Rehabilitation. 4th edition. New York:
Mcgraw-hill; 2011.
14. Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN:
A self-administered questionnaire for the assessment of severity of
symptoms and functional status in carpal tunnel syndrome. J Bone Joint
Surg 1993, 75:1585–1592.
15. Phalen GS: The carpal-tunnel syndrome seventeen years' experience in
diagnosis and treatment of six hundred fifty-four hands. J Bone Joint Surg
1966, 48:211–228.
16. Tinel J: The “tingling” sign in peripheral nerve lesions. Translated by E.
Kaplan. In M Spinner, Injuries to the Major Branches of Peripheral Nerves of the
Forearm. Philadelphia: Saunders; 1972:8–11.
17. Brininger TL, Rogers JC, Holm MB, Baker NA, Li Z-M, Goitz RJ: Efficacy of a
fabricated customized splint and tendon and nerve gliding exercises for
the treatment of carpal tunnel syndrome: a randomized controlled trial.
Arch Phys Med Rehabil 2007, 88:1429–1435.
18. Medicine AAE: American academy of physical medicine and rehabilitation.
Practice parameter for electrodiagnostic studies in carpal tunnel syndrome:
summary statement. Muscle Nerve 2002, 25:918–922.
19. Charles N, Vial C, Chauplannaz G, Bady B: Clinical validation of antidromic
stimulation of the ring finger in early electrodiagnosis of mild carpal
tunnel syndrome. Electroencephalogr Clin Neurophysiol 1990, 76:142–147.
20. Kimura J: The carpal tunnel syndrome: localization of conduction
abnormalities within the distal segment of the median nerve. Brain 1979,
102:619–635.
21. Milani P, Mondelli M, Ginanneschi F, Mazzocchio R, Rossi A: Progesterone-
new therapy in mild carpal tunnel syndrome? study design of a randomized
clinical trial for local therapy. J Brachial Plexus Peripher Nerv Inj 2010, 5:11.
22. Çeliker R, Arslan S, Inanc F: Corticosteroid injection vs. nonsteroidal
antiinflammatory drug and splinting in carpal tunnel syndrome. Am J P M R
2002, 81:182–186.
23. Hanley JA, Negassa A, Forrester JE: Statistical analysis of correlated data
using generalized estimating equations: an orientation. Am J Epidemiol
2003, 157:364–375.
24. Cohen J: Statistical Power Analysis for the Behavioral Sciences. London: UK:
Taylor and Francis; 2013.
25. Yildiz N, Atalay NS, Gungen GO, Sanal E, Akkaya N, Topuz O: Comparison of
ultrasound and ketoprofen phonophoresis in the treatment of carpal
tunnel syndrome. J Back Musculoskelet Rehabil 2011, 24:39–47.
26. Oztas O, Turan B, Bora I, Karakaya MK: Ultrasound therapy effect in carpal
tunnel syndrome. Arch Phys Med Rehabil 1998, 79:1540–1544.
27. Raso VVM, Barbieri CH, Mazzer N, Fasan VS: Can therapeutic ultrasound
influence the regeneration of peripheral nerves? J Neurosci Methods 2005,
142:185–192.
28. Young RR, Henneman E: Reversible block of nerve conduction by ultrasound:
Ultrasonic blocking of nerve fibers. Arch Neurol 1961, 4:83–89.
29. Preston DC, Shapiro BE: Electromyography and Neuromuscular Disorders:
Clinical-Electrophysiologic Correlations (Expert Consult - Online). Philadelphia:
PA:Elsevier Health Sciences; 2012.
30. Harris CM, Tanner E, Goldstein MN, Pettee DS: The surgical treatment of the
carpal-tunnel syndrome correlated with preoperative nerve-conduction
studies. J Bone Joint Surg Am 1979, 61:93–98.
31. Wu YH, Chen WS, Luh JJ, Chong FC: Thermal effect of sonophoresis for
accelerating the analgesic effect of local anesthetics on rat tail nerve.
Conf Proc IEEE Eng Med Biol Soc 2008, 2008:2504–2507.
doi:10.1186/1471-2474-15-399
Cite this article as: Chang et al.: Comparative effectiveness of
ultrasound and paraffin therapy in patients with carpal tunnel
syndrome: a randomized trial. BMC Musculoskeletal Disorders 2014 15:399.
